Principles of in vivo recovery and survival studies.
作者信息
Allain J P
出版信息
Scand J Haematol Suppl. 1984;40:161-3. doi: 10.1111/j.1600-0609.1984.tb02559.x.
Abstract
摘要
相似文献
1
Principles of in vivo recovery and survival studies.体内恢复与存活研究的原则。
Scand J Haematol Suppl. 1984;40:161-3. doi: 10.1111/j.1600-0609.1984.tb02559.x.
2
Calculations of factor VIII in vivo recovery and half-life.体内因子VIII回收率和半衰期的计算。
Scand J Haematol Suppl. 1984;40:165-74. doi: 10.1111/j.1600-0609.1984.tb02560.x.
3
Fractionation of factor VIII and IX--an overview.凝血因子 VIII 和 IX 的分级分离——概述。
Scand J Haematol Suppl. 1984;40:513-24. doi: 10.1111/j.1600-0609.1984.tb02611.x.
4
Innovative alternatives to human factor VIII.人凝血因子 VIII 的创新替代物。
Scand J Haematol Suppl. 1984;40:525-8. doi: 10.1111/j.1600-0609.1984.tb02612.x.
5
The importance of corticoids added to continued treatment with Factor VIII concentrates in the suppression of inhibitors in haemophilia A.
Thromb Haemost. 1984 Apr 30;51(2):217-21.
6
Characteristics of various factor VIII concentrates used in treatment of haemophilia A.用于治疗甲型血友病的各种凝血因子VIII浓缩剂的特性。
Br J Haematol. 1977 Dec;37(4):543-57. doi: 10.1111/j.1365-2141.1977.tb01028.x.
7
Principles of in vivo recovery and survival studies of VIII:C.VIII因子促凝活性的体内恢复与存活研究原理
Scand J Haematol Suppl. 1984;41:123-30. doi: 10.1111/j.1600-0609.1984.tb02773.x.
8
Comparison of the in vivo survival of human factor VIII with and without von Willebrand factor in the hemophilic dog.血友病犬体内人凝血因子VIII在有和没有血管性血友病因子情况下的存活情况比较。
Thromb Res. 1986 Feb 1;41(3):425-9. doi: 10.1016/0049-3848(86)90253-7.
9
Heparin and factor VIII.肝素与凝血因子 VIII。
Scand J Haematol Suppl. 1984;40:111-22. doi: 10.1111/j.1600-0609.1984.tb02552.x.
10
Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
Thromb Haemost. 1999 Mar;81(3):475-6.
引用本文的文献
1
Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.
Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002.
Zotero 插件